MAGE-12 peptide vaccine (National Cancer Institute)
N/A
Report date: 2024/04/18 14:32:43
Base Information
Drug NameMAGE-12 peptide vaccine (National Cancer Institute)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive Indications +[12]
Other Information
ATC CodeN/A
Related LinksN/A